The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 01, 2019

Filed:

Dec. 21, 2016
Applicants:

Kyushu University, National University Corporation, Fukuoka-Shi, Fukuoka, JP;

Kowa Company, Ltd., Nagoya-Shi, Aichi, JP;

Inventors:

Tatsuro Ishibashi, Fukuoka, JP;

Shintaro Nakao, Fukuoka, JP;

Ryoichi Arita, Fukuoka, JP;

Ken Mizuno, Higashimurayama, JP;

Akifumi Tsuchiura, Tokyo, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/551 (2006.01); A61K 9/00 (2006.01); A61K 31/496 (2006.01); C07D 401/12 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 31/551 (2013.01); A61K 9/0046 (2013.01); A61K 9/0048 (2013.01); A61K 31/496 (2013.01); C07D 401/12 (2013.01); A61K 47/10 (2013.01);
Abstract

Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.


Find Patent Forward Citations

Ishibashi, Tatsuro. (2019). Therapeutic agent for ocular fundus disease (U.S. Patent No. 10426783). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10426783

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…